FDA approval of deep brain stimulators will drive APAC market, says GlobalData
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
Alopecia areata usually presents as a few small bald patches in the head
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
The drug will be manufactured at the group’s topical facility at Ahmedabad
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopaedic recovery device, ManaSport.
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Subscribe To Our Newsletter & Stay Updated